Filter Results
:
(2,234)
Show Results For
-
All HBS Web
(2,234)
- News (359)
- Research (1,583)
- Events (17)
- Multimedia (22)
- Faculty Publications (911)
Show Results For
-
All HBS Web
(2,234)
- News (359)
- Research (1,583)
- Events (17)
- Multimedia (22)
- Faculty Publications (911)
- January 1987 (Revised May 1989)
- Case
Merck-Banyu
By: Timothy A. Luehrman
Merck acquired control of Banyu in 1983. This was the first acquisition by outsiders of a major publicly traded Japanese company. This case is focused on valuing strategic investments in an environment of global competition. The case is complex because of the...
View Details
Keywords:
Acquisition;
Investment;
Globalization;
Governing Rules, Regulations, and Reforms;
Industry Structures;
Negotiation Deal;
Public Ownership;
Competition;
Valuation;
Japan
Luehrman, Timothy A. "Merck-Banyu." Harvard Business School Case 287-061, January 1987. (Revised May 1989.)
- November 2006
- Case
Santander's Acquisition of Abbey: Banking across Borders
Banco Santander, Spain's largest commercial bank, announced in July 2004 the acquisition of Abbey National Bank, the fifth largest U.K. commercial bank. This transaction was the largest ever cross-border acquisition in European banking and would result in the...
View Details
Keywords:
Integration;
Value Creation;
Mergers and Acquisitions;
Globalization;
Commercial Banking;
Banking Industry;
United Kingdom;
European Union;
Spain
Ghemawat, Pankaj, Eduardo Ballarin, and Jose Manuel Campa. "Santander's Acquisition of Abbey: Banking across Borders." Harvard Business School Case 707-485, November 2006.
- February 2020 (Revised June 2020)
- Case
Shaping the Governance Debate at ISS
By: Suraj Srinivasan, Jonah S. Goldberg and Calvin O. Liou
ISS is the world’s largest provider of corporate governance research, data, analytics, and voting services. The case uses the effort of the Securities and Exchange Commission (SEC) to impose an array of new regulations that would severely restrict the functioning of...
View Details
Keywords:
Proxy Advisory Services;
Corporate Governance;
Research;
Investment;
Governing Rules, Regulations, and Reforms;
Business and Shareholder Relations;
Institutional Investing
Srinivasan, Suraj, Jonah S. Goldberg, and Calvin O. Liou. "Shaping the Governance Debate at ISS." Harvard Business School Case 120-085, February 2020. (Revised June 2020.)
- 2007
- Article
Pharmacovigilance and the Missing Denominator: The Changing Context of Pharmaceutical Risk Mitigation
By: Arthur A. Daemmrich
In the wake of Vioxx, Avandia, and other recent prominent cases of drugs found to cause side effects after marketing, the safety of pharmaceuticals has come to the forefront of American public policy. Press attention, congressional investigations, and legislative...
View Details
Keywords:
Brands and Branding;
Policy;
Risk Management;
Government Legislation;
Risk and Uncertainty;
Goals and Objectives;
Customers;
Pharmaceutical Industry;
Health Industry;
United States
Daemmrich, Arthur A. "Pharmacovigilance and the Missing Denominator: The Changing Context of Pharmaceutical Risk Mitigation." Pharmacy in History 49, no. 2 (2007): 61–75.
- Other Article
How to Make Remote Monitoring Tech Part of Everyday Health Care
By: Samantha F. Sanders, Ariel Dora Stern and William J. Gordon
Remote patient monitoring is a subset of telehealth that involves the collection, transmission, evaluation, and communication of patient health data from electronic devices. These devices include wearable sensors, implanted equipment, and handheld instruments. During...
View Details
Keywords:
Health Care and Treatment;
Information Technology;
Analytics and Data Science;
Technology Adoption
Sanders, Samantha F., Ariel Dora Stern, and William J. Gordon. "How to Make Remote Monitoring Tech Part of Everyday Health Care." Harvard Business Review (website) (July 2, 2020).
- June 2014
- Case
The Special Master for TARP Executive Compensation
By: Brian Hall, Aaron Chadbourne, Vibha Kagzi and Caren Kelleher
This case is about the response of the US government to the excessive compensation of executives following the market collapse of 2008. In particular, the case focuses on the special committee that was formed to oversee and regulate any financial companies that had...
View Details
Hall, Brian, Aaron Chadbourne, Vibha Kagzi, and Caren Kelleher. "The Special Master for TARP Executive Compensation." Harvard Business School Case 914-052, June 2014.
- November 2008 (Revised July 2009)
- Background Note
A Managerial Perspective on Clinical Trials
By: Arthur A. Daemmrich
This note describes the history and regulation of clinical trials, managerial challenges related to pharmaceutical product testing, and current debates regarding prescription drug safety. Since clinical testing takes between five and seven years, and consumes up to 70...
View Details
Keywords:
Governing Rules, Regulations, and Reforms;
Health Testing and Trials;
Product Development;
Safety;
Biotechnology Industry;
Pharmaceutical Industry
Daemmrich, Arthur A. "A Managerial Perspective on Clinical Trials." Harvard Business School Background Note 709-033, November 2008. (Revised July 2009.)
- January 2018 (Revised April 2021)
- Case
Capital Allocation at HCA
By: W. Carl Kester and Emily R. McComb
In early 2017, HCA Holdings, an investor-owned hospital management company, faced a strategically important capital allocation decision. After the exit of its private equity sponsors in 2016, HCA had to determine how best to allocate its substantial annual free cash...
View Details
Keywords:
Capital Allocation;
Cash Distribution Policy;
Dividends;
Share Repurchases;
Growth Strategy And Execution;
Growth Investing;
Capital Expenditures;
Debt Management;
Debt Reduction;
Debt Policy;
Hospital Management;
Investor-owned Hospital Chains;
Capital Budgeting;
Capital Structure;
Cash Flow;
Corporate Finance;
Decision Choices and Conditions;
Health Industry;
United States
Kester, W. Carl, and Emily R. McComb. "Capital Allocation at HCA." Harvard Business School Case 218-039, January 2018. (Revised April 2021.)
- Research Summary
Drivers of market entry
In this paper, I look at the selection of markets for entry. Specifically, regulation in the US pharmaceutical industry allows generic firms to try and enter the market prior to the expiration of patents. This work aims to understand what drives market entry,...
View Details
- March 2015 (Revised November 2017)
- Case
Bonitas
By: Regina E. Herzlinger and Natalie Kindred
Bonitas, a South African medical scheme (i.e., health insurer), must navigate highly restrictive regulations that make it difficult for Bonitas to innovate, grow, and compete with market leader Discovery as well as providers of alternative insurance products. Bonitas...
View Details
Keywords:
Health Insurance;
Health Care;
South Africa;
Medical Scheme;
Public Policy;
Bonitas;
Bonitas Medical Fund;
National Health Insurance;
Health;
Health Care and Treatment;
Insurance;
Policy;
Health Industry;
Insurance Industry;
South Africa;
Johannesburg;
Africa
Herzlinger, Regina E., and Natalie Kindred. "Bonitas." Harvard Business School Case 315-020, March 2015. (Revised November 2017.)
- Web
Faculty & Research
new markets while reinforcing adoption where the KDPs had already been launched, and the decisions made would shape the path forward. HBS Working Paper Pricing of Climate Risk Insurance: Regulation and Cross-Subsidies By: Ishita Sen ,...
View Details
David A. Moss
David Moss is the Paul Whiton Cherington Professor at Harvard Business School, where he teaches in the Business, Government, and the International Economy (BGIE) unit. He earned his B.A. from Cornell University and his Ph.D. from Yale. In 1992-1993, he served as a... View Details
- 25 Jul 2014
- News
Expensive Small Business Lenders Are Unregulated. Should They Be?
- 17 Jan 2013
- News
What to do now: Shape up
- January 11, 2024
- Article
Understanding the Tradeoffs of the Amazon Antitrust Case
By: Chiara Farronato, Andrey Fradkin, Andrei Hagiu and Dionne Lomax
Regulators in the United States and Europe have been taking on Big Tech, challenging what they say are the companies’ anti-competitive and predatory strategies that harm consumers and third-party users of their platforms. This article examines the FTC’s case against...
View Details
Keywords:
Monopoly;
Governing Rules, Regulations, and Reforms;
Market Design;
Lawsuits and Litigation
Farronato, Chiara, Andrey Fradkin, Andrei Hagiu, and Dionne Lomax. "Understanding the Tradeoffs of the Amazon Antitrust Case." Harvard Business Review Digital Articles (January 11, 2024).
- 2007
- Chapter
Microfinance: Business, Profitability, and the Creation of Social Value
By: Michael Chu
The chapter examines the development of microfinance from its NGO origins to the present stage in which it is characterized by regulated commercial institutions capable of superior financial returns. It then looks at the creation of social value under these...
View Details
Keywords:
Microfinance;
Investment Return;
Profit;
Governing Rules, Regulations, and Reforms;
Social Enterprise;
Non-Governmental Organizations;
Perspective;
Value Creation
Chu, Michael. "Microfinance: Business, Profitability, and the Creation of Social Value." Chap. 28 in Business Solutions for the Global Poor: Creating Social and Economic Value, by V. Kasturi Rangan, John A. Quelch, Gustavo Herrero, and Brooke Barton, 309–320. John Wiley & Sons, 2007.
- 14 Apr 2008
- News
The Gap in the U.S. Treasury Recommendations
- 02 Nov 2016
- HBS Seminar